The study is currently in progress.
The objectives of this study include:
1) Describe the clinical and immunological phenotype in patients with IL2RA and IL2RB deficiencies
2) Describe the outcome of HSCT in these two disorders
3) Explore the impact of CMV serostatus and CMV disease at HSCT on outcome
4) Explore the impact of donor chimerism on immunophenotype and disease activity post-HSCT
Over the past few months, ESID Education Committee (including Juniors and PIDCD working parties) has updated and refined the ESID Fellowships Program to ensure a smoother application and review process for all applicants.
We are pleased to announce the program is now open and continues to offer two distinct opportunities – observership grant and research fellowship – for ESID members to expand their expertise, strengthen inter-institutional collaboration, and advance research and care in Primary Immunodeficiencies (PIDs). You can find more information about each below and apply by November 10th!
Over the past few months, ESID Education Committee (including Juniors and PIDCD working parties) has updated and refined the ESID Fellowships Program to ensure a smoother application and review process for all applicants.
We are pleased to announce the program is now open and continues to offer two distinct opportunities – observership grant and research fellowship – for ESID members to expand their expertise, strengthen inter-institutional collaboration, and advance research and care in Primary Immunodeficiencies (PIDs). You can find more information about each below and apply by November 10th!
ESID Fellowships are a great way not only to finance your projects in the field of PIDs but also to expand your professional network, exchange knowledge, increase your expertise and move your career to a new level. Through an ESID Fellowship, you can find new opportunities and start new collaborative projects.
Dear ESID Members,
We extend a warm invitation to you to apply for the ESID 5th PID Care in Development (PIDCD) School in Split, Croatia taking place from the 26th to the 28th of November 2026. You can find more information on the School and Application process below.
This school is oriented to professionals in the need of expanding their knowledge on Primary Immunodeficiencies for their daily work, due to the absence of reference centers for PIDs in their surroundings.
Dear ESID Members,
We extend a warm invitation to you to apply for the ESID 4th PID Care in Development (PIDCD) School in Split, Croatia taking place from the 11 th to the 13 th of December 2025.
This school is oriented to professionals in the need of expanding their knowledge on Primary Immunodeficiencies for their daily work, due to the absence of reference centers for PIDs in their surroundings.
The Laboratory for Inborn Errors of Immunity at the KU Leuven (Faculty of Medicine, Department of Microbiology/Immunology/Transplantation, Prof. Dr. Isabelle Meyts) is seeking a highly motivated and talented PhD student. Our lab investigates the genetic and molecular basis of inborn errors of immunity, with a strong focus on translational and fundamental research.
ESID EHA SIOPE Focused Symposium 2025
“The Interplay of Immunology & Haematology” gathered 800 clinical experts, researchers, early careers, and other HCPs came together in Vienna to elevate the care and outcomes of their immunodeficiency, haematology and cancer patients.
It is with deep emotion that the ESID board announces the passing of Professor Claude Griscelli on May 7th in Rabat, Morocco. A paediatrician, world-renowned immunologist, former Director of the Inserm institute and founding President of the Institute Imagine in Paris, Professor Griscelli leaves behind an inestimable scientific and human legacy, entirely committed to children’s health and biomedical research.
We are pleased to share with you a series of upcoming calls and opportunities for ESID members over the next few months. These initiatives offer valuable ways to engage with the ESID community, contribute to its activities, and advance your professional development.
